National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 460432

History of Changes from the VAERS Wayback Machine

First Appeared on 8/13/2012

VAERS ID: 460432
VAERS Form:
Age:1.3
Sex:Female
Location:New Jersey
Vaccinated:2012-07-16
Onset:2012-07-22
Submitted:2012-07-27
Entered:2012-07-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 02771AE / 0 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 1577 / 0 UN / UN
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH E56178 / - UN / UN

Administered by: Private      Purchased by: Other
Symptoms: Acidosis, Acute myeloid leukaemia, Anaemia, Aspiration bone marrow abnormal, Blood culture, Culture urine, Death, Diarrhoea, Full blood count abnormal, Hypercapnia, Leukocytosis, Oxygen saturation decreased, Pyrexia, Tachycardia, Tachypnoea, Thrombocytopenia, Vomiting, Central venous catheterisation, Postoperative respiratory distress, Blast cells present, Bilevel positive airway pressure, Bacterial test negative, Mechanical ventilation, Endotracheal intubation

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2012-07-22
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: (all medications received between admission 7/17/12 and death 7/22/12); Aluminum hydroxide suspension; Diphenhydramine; Acetaminophen; Propofol; Allopurinol; Cefepime; Ondansetron; Cytarabine; Morphine; Dexamethasone; Albuterol (inhaled); D
Current Illness: AML
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Autopsy is pending
CDC 'Split Type':

Write-up: The patient had a screening CBC done the same day as vaccinations (7/16/12) that showed leukocytosis with blasts, anemia and thrombocytopenia. She was admitted to the hospital on 7/17/12. On 7/19/12, she was diagnosed with AML by bone marrow aspirate. She also started having fever and was started on broad spectrum antibiotics. Had surgical placement of CVC on 7/20/12 and received intrathecal cytarabine. She had postoperative respiratory issues, which was treated with high flow nasal cannula oxygen and diuretics. On 7/21/12, she received dexamethasone, cytarabine, daunorubicin and etoposide. Bortezomib (a tyrosine kinase inhibitor) was given per experimental treatment protocol. Beginning 7/21/12, she developed vomiting, diarrhea, tachypnea and tachycardia with worsening desaturations. She progressed over the course of the day on 7/22/12 despite increasing respiratory support from high flow nasal cannula oxygen to bilevel positive airway pressure, to endotracheal intubation with mechanical ventilation. The team caring for her was unable to increase oxygenation, improve carbon dioxide retention or correct acidosis. The patient died on 7/22/12 at 2151. Cultures from blood and urine did not grow bacteria. An autopsy is being done.


Changed on 10/14/2012

VAERS ID: 460432 Before After
VAERS Form:
Age:1.3
Sex:Female
Location:New Jersey
Vaccinated:2012-07-16
Onset:2012-07-22
Submitted:2012-07-27
Entered:2012-07-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 02771AE / 0 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 1577 / 0 UN / UN
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH E56178 / - UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH E56178 / - UN / UN

Administered by: Private      Purchased by: Other
Symptoms: Acidosis, Acute myeloid leukaemia, Anaemia, Aspiration bone marrow abnormal, Blood culture, Culture urine, Death, Diarrhoea, Full blood count abnormal, Hypercapnia, Leukocytosis, Oxygen saturation decreased, Pyrexia, Tachycardia, Tachypnoea, Thrombocytopenia, Vomiting, Central venous catheterisation, Postoperative respiratory distress, Blast cells present, Bilevel positive airway pressure, Bacterial test negative, Mechanical ventilation, Endotracheal intubation

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2012-07-22
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: (all medications received between admission 7/17/12 and death 7/22/12); Aluminum hydroxide suspension; Diphenhydramine; Acetaminophen; Propofol; Allopurinol; Cefepime; Ondansetron; Cytarabine; Morphine; Dexamethasone; Albuterol (inhaled); D
Current Illness: AML
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Autopsy is pending
CDC 'Split Type':

Write-up: The patient had a screening CBC done the same day as vaccinations (7/16/12) that showed leukocytosis with blasts, anemia and thrombocytopenia. She was admitted to the hospital on 7/17/12. On 7/19/12, she was diagnosed with AML by bone marrow aspirate. She also started having fever and was started on broad spectrum antibiotics. Had surgical placement of CVC on 7/20/12 and received intrathecal cytarabine. She had postoperative respiratory issues, which was treated with high flow nasal cannula oxygen and diuretics. On 7/21/12, she received dexamethasone, cytarabine, daunorubicin and etoposide. Bortezomib (a tyrosine kinase inhibitor) was given per experimental treatment protocol. Beginning 7/21/12, she developed vomiting, diarrhea, tachypnea and tachycardia with worsening desaturations. She progressed over the course of the day on 7/22/12 despite increasing respiratory support from high flow nasal cannula oxygen to bilevel positive airway pressure, to endotracheal intubation with mechanical ventilation. The team caring for her was unable to increase oxygenation, improve carbon dioxide retention or correct acidosis. The patient died on 7/22/12 at 2151. Cultures from blood and urine did not grow bacteria. An autopsy is being done.


Changed on 6/14/2014

VAERS ID: 460432 Before After
VAERS Form:
Age:1.3
Sex:Female
Location:New Jersey
Vaccinated:2012-07-16
Onset:2012-07-22
Submitted:2012-07-27
Entered:2012-07-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 02771AE / 0 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 1577 / 0 UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH E56178 / - UN / UN

Administered by: Private      Purchased by: Other
Symptoms: Acidosis, Acute myeloid leukaemia, Anaemia, Aspiration bone marrow abnormal, Blood culture, Culture urine, Death, Diarrhoea, Full blood count abnormal, Hypercapnia, Leukocytosis, Oxygen saturation decreased, Pyrexia, Tachycardia, Tachypnoea, Thrombocytopenia, Vomiting, Central venous catheterisation, Postoperative respiratory distress, Blast cells present, Bilevel positive airway pressure, Bacterial test negative, Mechanical ventilation, Endotracheal intubation

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2012-07-22
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: (all medications received between admission 7/17/12 and death 7/22/12); Aluminum hydroxide suspension; Diphenhydramine; Acetaminophen; Propofol; Allopurinol; Cefepime; Ondansetron; Cytarabine; Morphine; Dexamethasone; Albuterol (inhaled); D
Current Illness: AML
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Autopsy is pending
CDC 'Split Type':

Write-up: The patient had a screening CBC done the same day as vaccinations (7/16/12) that showed leukocytosis with blasts, anemia and thrombocytopenia. She was admitted to the hospital on 7/17/12. On 7/19/12, she was diagnosed with AML by bone marrow aspirate. She also started having fever and was started on broad spectrum antibiotics. Had surgical placement of CVC on 7/20/12 and received intrathecal cytarabine. She had postoperative respiratory issues, which was treated with high flow nasal cannula oxygen and diuretics. On 7/21/12, she received dexamethasone, cytarabine, daunorubicin and etoposide. Bortezomib (a tyrosine kinase inhibitor) was given per experimental treatment protocol. Beginning 7/21/12, she developed vomiting, diarrhea, tachypnea and tachycardia with worsening desaturations. She progressed over the course of the day on 7/22/12 despite increasing respiratory support from high flow nasal cannula oxygen to bilevel positive airway pressure, to endotracheal intubation with mechanical ventilation. The team caring for her was unable to increase oxygenation, improve carbon dioxide retention or correct acidosis. The patient died on 7/22/12 at 2151. Cultures from blood and urine did not grow bacteria. An autopsy is being done.


Changed on 2/14/2017

VAERS ID: 460432 Before After
VAERS Form:
Age:1.3 1.28
Sex:Female
Location:New Jersey
Vaccinated:2012-07-16
Onset:2012-07-22
Submitted:2012-07-27
Entered:2012-07-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 02771AE / 0 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 1577 / 0 UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH E56178 / - UN / UN

Administered by: Private      Purchased by: Other
Symptoms: Acidosis, Acute myeloid leukaemia, Anaemia, Aspiration bone marrow abnormal, Blood culture, Culture urine, Death, Diarrhoea, Full blood count abnormal, Hypercapnia, Leukocytosis, Oxygen saturation decreased, Pyrexia, Tachycardia, Tachypnoea, Thrombocytopenia, Vomiting, Central venous catheterisation, Postoperative respiratory distress, Blast cells present, Bilevel positive airway pressure, Bacterial test negative, Mechanical ventilation, Endotracheal intubation

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2012-07-22
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: (all medications received between admission 7/17/12 and death 7/22/12); Aluminum hydroxide suspension; Diphenhydramine; Acetaminophen; Propofol; Allopurinol; Cefepime; Ondansetron; Cytarabine; Morphine; Dexamethasone; Albuterol (inhaled); D
Current Illness: AML
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Autopsy is pending
CDC 'Split Type':

Write-up: The patient had a screening CBC done the same day as vaccinations (7/16/12) that showed leukocytosis with blasts, anemia and thrombocytopenia. She was admitted to the hospital on 7/17/12. On 7/19/12, she was diagnosed with AML by bone marrow aspirate. She also started having fever and was started on broad spectrum antibiotics. Had surgical placement of CVC on 7/20/12 and received intrathecal cytarabine. She had postoperative respiratory issues, which was treated with high flow nasal cannula oxygen and diuretics. On 7/21/12, she received dexamethasone, cytarabine, daunorubicin and etoposide. Bortezomib (a tyrosine kinase inhibitor) was given per experimental treatment protocol. Beginning 7/21/12, she developed vomiting, diarrhea, tachypnea and tachycardia with worsening desaturations. She progressed over the course of the day on 7/22/12 despite increasing respiratory support from high flow nasal cannula oxygen to bilevel positive airway pressure, to endotracheal intubation with mechanical ventilation. The team caring for her was unable to increase oxygenation, improve carbon dioxide retention or correct acidosis. The patient died on 7/22/12 at 2151. Cultures from blood and urine did not grow bacteria. An autopsy is being done.


Changed on 9/14/2017

VAERS ID: 460432 Before After
VAERS Form:(blank) 1
Age:1.28
Sex:Female
Location:New Jersey
Vaccinated:2012-07-16
Onset:2012-07-22
Submitted:2012-07-27
Entered:2012-07-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 02771AE / 0 1 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 1577 / 0 1 UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH E56178 / - UNK UN / UN

Administered by: Private      Purchased by: Other
Symptoms: Acidosis, Acute myeloid leukaemia, Anaemia, Aspiration bone marrow abnormal, Blood culture, Culture urine, Death, Diarrhoea, Full blood count abnormal, Hypercapnia, Leukocytosis, Oxygen saturation decreased, Pyrexia, Tachycardia, Tachypnoea, Thrombocytopenia, Vomiting, Central venous catheterisation, Postoperative respiratory distress, Blast cells present, Bilevel positive airway pressure, Bacterial test negative, Mechanical ventilation, Endotracheal intubation

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2012-07-22
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: (all medications received between admission 7/17/12 and death 7/22/12); Aluminum hydroxide suspension; Diphenhydramine; Acetaminophen; Propofol; Allopurinol; Cefepime; Ondansetron; Cytarabine; Morphine; Dexamethasone; Albuterol (inhaled); D
Current Illness: AML
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Autopsy is pending
CDC 'Split Type':

Write-up: The patient had a screening CBC done the same day as vaccinations (7/16/12) that showed leukocytosis with blasts, anemia and thrombocytopenia. She was admitted to the hospital on 7/17/12. On 7/19/12, she was diagnosed with AML by bone marrow aspirate. She also started having fever and was started on broad spectrum antibiotics. Had surgical placement of CVC on 7/20/12 and received intrathecal cytarabine. She had postoperative respiratory issues, which was treated with high flow nasal cannula oxygen and diuretics. On 7/21/12, she received dexamethasone, cytarabine, daunorubicin and etoposide. Bortezomib (a tyrosine kinase inhibitor) was given per experimental treatment protocol. Beginning 7/21/12, she developed vomiting, diarrhea, tachypnea and tachycardia with worsening desaturations. She progressed over the course of the day on 7/22/12 despite increasing respiratory support from high flow nasal cannula oxygen to bilevel positive airway pressure, to endotracheal intubation with mechanical ventilation. The team caring for her was unable to increase oxygenation, improve carbon dioxide retention or correct acidosis. The patient died on 7/22/12 at 2151. Cultures from blood and urine did not grow bacteria. An autopsy is being done.


Changed on 2/14/2018

VAERS ID: 460432 Before After
VAERS Form:1
Age:1.28
Sex:Female
Location:New Jersey
Vaccinated:2012-07-16
Onset:2012-07-22
Submitted:2012-07-27
Entered:2012-07-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 02771AE / 1 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 1577 / 1 UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH E56178 / UNK UN / UN

Administered by: Private      Purchased by: Other
Symptoms: Acidosis, Acute myeloid leukaemia, Anaemia, Aspiration bone marrow abnormal, Blood culture, Culture urine, Death, Diarrhoea, Full blood count abnormal, Hypercapnia, Leukocytosis, Oxygen saturation decreased, Pyrexia, Tachycardia, Tachypnoea, Thrombocytopenia, Vomiting, Central venous catheterisation, Postoperative respiratory distress, Blast cells present, Bilevel positive airway pressure, Bacterial test negative, Mechanical ventilation, Endotracheal intubation

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2012-07-22
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: (all medications received between admission 7/17/12 and death 7/22/12); Aluminum hydroxide suspension; Diphenhydramine; Acetaminophen; Propofol; Allopurinol; Cefepime; Ondansetron; Cytarabine; Morphine; Dexamethasone; Albuterol (inhaled); D
Current Illness: AML
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Autopsy is pending
CDC 'Split Type':

Write-up: The patient had a screening CBC done the same day as vaccinations (7/16/12) that showed leukocytosis with blasts, anemia and thrombocytopenia. She was admitted to the hospital on 7/17/12. On 7/19/12, she was diagnosed with AML by bone marrow aspirate. She also started having fever and was started on broad spectrum antibiotics. Had surgical placement of CVC on 7/20/12 and received intrathecal cytarabine. She had postoperative respiratory issues, which was treated with high flow nasal cannula oxygen and diuretics. On 7/21/12, she received dexamethasone, cytarabine, daunorubicin and etoposide. Bortezomib (a tyrosine kinase inhibitor) was given per experimental treatment protocol. Beginning 7/21/12, she developed vomiting, diarrhea, tachypnea and tachycardia with worsening desaturations. She progressed over the course of the day on 7/22/12 despite increasing respiratory support from high flow nasal cannula oxygen to bilevel positive airway pressure, to endotracheal intubation with mechanical ventilation. The team caring for her was unable to increase oxygenation, improve carbon dioxide retention or correct acidosis. The patient died on 7/22/12 at 2151. Cultures from blood and urine did not grow bacteria. An autopsy is being done.


Changed on 6/14/2018

VAERS ID: 460432 Before After
VAERS Form:1
Age:1.28
Sex:Female
Location:New Jersey
Vaccinated:2012-07-16
Onset:2012-07-22
Submitted:2012-07-27
Entered:2012-07-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 02771AE / 1 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 1577 / 1 UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH E56178 / UNK UN / UN

Administered by: Private      Purchased by: Other
Symptoms: Acidosis, Acute myeloid leukaemia, Anaemia, Aspiration bone marrow abnormal, Blood culture, Culture urine, Death, Diarrhoea, Full blood count abnormal, Hypercapnia, Leukocytosis, Oxygen saturation decreased, Pyrexia, Tachycardia, Tachypnoea, Thrombocytopenia, Vomiting, Central venous catheterisation, Postoperative respiratory distress, Blast cells present, Bilevel positive airway pressure, Bacterial test negative, Mechanical ventilation, Endotracheal intubation

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2012-07-22
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: (all medications received between admission 7/17/12 and death 7/22/12); Aluminum hydroxide suspension; Diphenhydramine; Acetaminophen; Propofol; Allopurinol; Cefepime; Ondansetron; Cytarabine; Morphine; Dexamethasone; Albuterol (inhaled); D
Current Illness: AML
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Autopsy is pending
CDC 'Split Type':

Write-up: The patient had a screening CBC done the same day as vaccinations (7/16/12) that showed leukocytosis with blasts, anemia and thrombocytopenia. She was admitted to the hospital on 7/17/12. On 7/19/12, she was diagnosed with AML by bone marrow aspirate. She also started having fever and was started on broad spectrum antibiotics. Had surgical placement of CVC on 7/20/12 and received intrathecal cytarabine. She had postoperative respiratory issues, which was treated with high flow nasal cannula oxygen and diuretics. On 7/21/12, she received dexamethasone, cytarabine, daunorubicin and etoposide. Bortezomib (a tyrosine kinase inhibitor) was given per experimental treatment protocol. Beginning 7/21/12, she developed vomiting, diarrhea, tachypnea and tachycardia with worsening desaturations. She progressed over the course of the day on 7/22/12 despite increasing respiratory support from high flow nasal cannula oxygen to bilevel positive airway pressure, to endotracheal intubation with mechanical ventilation. The team caring for her was unable to increase oxygenation, improve carbon dioxide retention or correct acidosis. The patient died on 7/22/12 at 2151. Cultures from blood and urine did not grow bacteria. An autopsy is being done.


Changed on 8/14/2018

VAERS ID: 460432 Before After
VAERS Form:1
Age:1.28
Sex:Female
Location:New Jersey
Vaccinated:2012-07-16
Onset:2012-07-22
Submitted:2012-07-27
Entered:2012-07-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 02771AE / 1 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 1577 / 1 UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH E56178 / UNK UN / UN

Administered by: Private      Purchased by: Other
Symptoms: Acidosis, Acute myeloid leukaemia, Anaemia, Aspiration bone marrow abnormal, Blood culture, Culture urine, Death, Diarrhoea, Full blood count abnormal, Hypercapnia, Leukocytosis, Oxygen saturation decreased, Pyrexia, Tachycardia, Tachypnoea, Thrombocytopenia, Vomiting, Central venous catheterisation, Postoperative respiratory distress, Blast cells present, Bilevel positive airway pressure, Bacterial test negative, Mechanical ventilation, Endotracheal intubation

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2012-07-22
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: (all medications received between admission 7/17/12 and death 7/22/12); Aluminum hydroxide suspension; Diphenhydramine; Acetaminophen; Propofol; Allopurinol; Cefepime; Ondansetron; Cytarabine; Morphine; Dexamethasone; Albuterol (inhaled); D
Current Illness: AML
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Autopsy is pending
CDC 'Split Type':

Write-up: The patient had a screening CBC done the same day as vaccinations (7/16/12) that showed leukocytosis with blasts, anemia and thrombocytopenia. She was admitted to the hospital on 7/17/12. On 7/19/12, she was diagnosed with AML by bone marrow aspirate. She also started having fever and was started on broad spectrum antibiotics. Had surgical placement of CVC on 7/20/12 and received intrathecal cytarabine. She had postoperative respiratory issues, which was treated with high flow nasal cannula oxygen and diuretics. On 7/21/12, she received dexamethasone, cytarabine, daunorubicin and etoposide. Bortezomib (a tyrosine kinase inhibitor) was given per experimental treatment protocol. Beginning 7/21/12, she developed vomiting, diarrhea, tachypnea and tachycardia with worsening desaturations. She progressed over the course of the day on 7/22/12 despite increasing respiratory support from high flow nasal cannula oxygen to bilevel positive airway pressure, to endotracheal intubation with mechanical ventilation. The team caring for her was unable to increase oxygenation, improve carbon dioxide retention or correct acidosis. The patient died on 7/22/12 at 2151. Cultures from blood and urine did not grow bacteria. An autopsy is being done.


Changed on 9/14/2018

VAERS ID: 460432 Before After
VAERS Form:1
Age:1.28
Sex:Female
Location:New Jersey
Vaccinated:2012-07-16
Onset:2012-07-22
Submitted:2012-07-27
Entered:2012-07-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 02771AE / 1 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 1577 / 1 UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH E56178 / UNK UN / UN

Administered by: Private      Purchased by: Other
Symptoms: Acidosis, Acute myeloid leukaemia, Anaemia, Aspiration bone marrow abnormal, Blood culture, Culture urine, Death, Diarrhoea, Full blood count abnormal, Hypercapnia, Leukocytosis, Oxygen saturation decreased, Pyrexia, Tachycardia, Tachypnoea, Thrombocytopenia, Vomiting, Central venous catheterisation, Postoperative respiratory distress, Blast cells present, Bilevel positive airway pressure, Bacterial test negative, Mechanical ventilation, Endotracheal intubation

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2012-07-22
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: (all medications received between admission 7/17/12 and death 7/22/12); Aluminum hydroxide suspension; Diphenhydramine; Acetaminophen; Propofol; Allopurinol; Cefepime; Ondansetron; Cytarabine; Morphine; Dexamethasone; Albuterol (inhaled); D
Current Illness: AML
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Autopsy is pending
CDC 'Split Type':

Write-up: The patient had a screening CBC done the same day as vaccinations (7/16/12) that showed leukocytosis with blasts, anemia and thrombocytopenia. She was admitted to the hospital on 7/17/12. On 7/19/12, she was diagnosed with AML by bone marrow aspirate. She also started having fever and was started on broad spectrum antibiotics. Had surgical placement of CVC on 7/20/12 and received intrathecal cytarabine. She had postoperative respiratory issues, which was treated with high flow nasal cannula oxygen and diuretics. On 7/21/12, she received dexamethasone, cytarabine, daunorubicin and etoposide. Bortezomib (a tyrosine kinase inhibitor) was given per experimental treatment protocol. Beginning 7/21/12, she developed vomiting, diarrhea, tachypnea and tachycardia with worsening desaturations. She progressed over the course of the day on 7/22/12 despite increasing respiratory support from high flow nasal cannula oxygen to bilevel positive airway pressure, to endotracheal intubation with mechanical ventilation. The team caring for her was unable to increase oxygenation, improve carbon dioxide retention or correct acidosis. The patient died on 7/22/12 at 2151. Cultures from blood and urine did not grow bacteria. An autopsy is being done.


Changed on 10/14/2018

VAERS ID: 460432 Before After
VAERS Form:1
Age:1.28
Sex:Female
Location:New Jersey
Vaccinated:2012-07-16
Onset:2012-07-22
Submitted:2012-07-27
Entered:2012-07-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 02771AE / 1 UN / UN
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 1577 / 1 UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH E56178 / UNK UN / UN

Administered by: Private      Purchased by: Other
Symptoms: Acidosis, Acute myeloid leukaemia, Anaemia, Aspiration bone marrow abnormal, Blood culture, Culture urine, Death, Diarrhoea, Full blood count abnormal, Hypercapnia, Leukocytosis, Oxygen saturation decreased, Pyrexia, Tachycardia, Tachypnoea, Thrombocytopenia, Vomiting, Central venous catheterisation, Postoperative respiratory distress, Blast cells present, Bilevel positive airway pressure, Bacterial test negative, Mechanical ventilation, Endotracheal intubation

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2012-07-22
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: (all medications received between admission 7/17/12 and death 7/22/12); Aluminum hydroxide suspension; Diphenhydramine; Acetaminophen; Propofol; Allopurinol; Cefepime; Ondansetron; Cytarabine; Morphine; Dexamethasone; Albuterol (inhaled); D
Current Illness: AML
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Autopsy is pending
CDC 'Split Type':

Write-up: The patient had a screening CBC done the same day as vaccinations (7/16/12) that showed leukocytosis with blasts, anemia and thrombocytopenia. She was admitted to the hospital on 7/17/12. On 7/19/12, she was diagnosed with AML by bone marrow aspirate. She also started having fever and was started on broad spectrum antibiotics. Had surgical placement of CVC on 7/20/12 and received intrathecal cytarabine. She had postoperative respiratory issues, which was treated with high flow nasal cannula oxygen and diuretics. On 7/21/12, she received dexamethasone, cytarabine, daunorubicin and etoposide. Bortezomib (a tyrosine kinase inhibitor) was given per experimental treatment protocol. Beginning 7/21/12, she developed vomiting, diarrhea, tachypnea and tachycardia with worsening desaturations. She progressed over the course of the day on 7/22/12 despite increasing respiratory support from high flow nasal cannula oxygen to bilevel positive airway pressure, to endotracheal intubation with mechanical ventilation. The team caring for her was unable to increase oxygenation, improve carbon dioxide retention or correct acidosis. The patient died on 7/22/12 at 2151. Cultures from blood and urine did not grow bacteria. An autopsy is being done.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=460432&WAYBACKHISTORY=ON


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166